Stocks · Health care · Pharmaceutical Preparations

Dianthus Therapeutics, Inc.

DNTH Clue Score33
United States Fiscal year ends December CIK 0001690585 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Third Rock Ventures IV, L.P.
8 Feb 2023
10% owner
Sell
1,500,000
$0.82
$1.23M
Third Rock Ventures IV, L.P.
7 Feb 2023
10% owner
Sell
2,200,000
$0.83
$1.83M
David Wayne Nichols
16 Sep 2021
Chief Technical Officer
Sell
5,694
$6.73
$38.32K
Lisa Olson
16 Sep 2021
See Remarks
Sell
5,736
$6.73
$38.60K
Thomas W. Beetham
16 Sep 2021
See Remarks
Sell
6,103
$6.73
$41.07K
Jason Gardner
16 Sep 2021
See Remarks
Sell
14,340
$6.73
$96.51K
Caren Deardorf
16 Sep 2021
Chief Commercial Officer
Sell
6,238
$6.73
$41.98K
Stephen F. Mahoney
16 Sep 2021
See Remarks
Sell
5,736
$6.73
$38.60K
Kristen Stants
16 Sep 2021
Chief People Officer
Sell
5,736
$6.73
$38.60K
Jason Gardner
10 Jan 2020
See Remarks
Sell
11,200
$15.25
$170.80K
Jason Gardner
2 Jan 2020
See Remarks
Sell
2,800
$15.10
$42.28K
Zoran Zdraveski
24 Dec 2019
See Remarks
Sell
7,902
$16.00
$126.43K
Christina K. Isacson
24 Dec 2019
Chief Business Officer
Sell
4,463
$16.01
$71.45K
Jason Gardner
23 Dec 2019
See Remarks
Sell
2,897
$15.10
$43.75K
Christina K. Isacson
23 Dec 2019
Chief Business Officer
Sell
9,867
$16.03
$158.17K
Zoran Zdraveski
23 Dec 2019
See Remarks
Sell
4,181
$16.03
$67.02K
Jason Gardner
20 Dec 2019
See Remarks
Sell
76,711
$15.16
$1.16M
Jason Gardner
10 Dec 2019
See Remarks
Sell
4,392
$15.10
$66.32K
Michael P. Cooke
2 Dec 2019
Chief Scientific Officer
Sell
2,500
$13.21
$33.04K
Michael P. Cooke
2 Dec 2019
Chief Scientific Officer
Sell
1,373
$13.31
$18.28K
Michael P. Cooke
2 Dec 2019
Chief Scientific Officer
Sell
3,627
$12.74
$46.20K
Michael P. Cooke
20 Nov 2019
Chief Scientific Officer
Sell
5,000
$12.00
$60.00K
Michael P. Cooke
1 Nov 2019
Chief Scientific Officer
Sell
5,000
$10.67
$53.33K
Michael P. Cooke
1 Oct 2019
Chief Scientific Officer
Sell
5,000
$10.01
$50.06K
Michael P. Cooke
19 Sep 2019
Chief Scientific Officer
Sell
1,656
$12.00
$19.87K
Michael P. Cooke
12 Sep 2019
Chief Scientific Officer
Sell
844
$12.00
$10.13K
Michael P. Cooke
3 Sep 2019
Chief Scientific Officer
Sell
5,000
$10.11
$50.53K
Michael P. Cooke
1 Aug 2019
Chief Scientific Officer
Sell
2,500
$13.41
$33.52K
Michael P. Cooke
1 Aug 2019
Chief Scientific Officer
Sell
5,000
$13.42
$67.11K
Michael P. Cooke
1 Jul 2019
Chief Scientific Officer
Sell
2,500
$14.42
$36.05K
Michael P. Cooke
1 Jul 2019
Chief Scientific Officer
Sell
5,000
$14.39
$71.93K
Jason Gardner
21 Jun 2019
See Remarks
Sell
12,331
$15.11
$186.32K
Christina K. Isacson
21 Jun 2019
Chief Business Officer
Sell
5,415
$16.07
$87.02K
Jason Gardner
20 Jun 2019
See Remarks
Sell
1,669
$15.10
$25.20K
Michael P. Cooke
17 Jun 2019
Chief Scientific Officer
Sell
7,500
$13.90
$104.27K
Bruce Booth
20 Mar 2019
Director
Sell indirect
14,245
$17.86
$254.42K
Atlas Venture Fund X, L.P.
20 Mar 2019
10% owner
Sell indirect
14,245
$17.86
$254.42K

What was left out

Form 4 filings counted 242
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 71
Sales at will 37
Transactions with no price 0
Shares from compensation/vesting 32,438,229
Sales filed before the plan box existed 37
History held since 27 Jun 2018